|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01069 CN HEALTH TECH
Nominal 
0.400 -0.005 (-1.235%) | 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 34,393 | 10.546% | 31,112 | 19,020 | 23,021 | 3,777 |
| Cost of Sales | (30,256) | 6.780% | (28,335) | (15,262) | (17,952) | (3,864) |
| Gross Profit | 4,137 | 48.974% | 2,777 | 3,758 | 5,069 | (87) |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | 202,024 | -- | -- | |
| Share of Results of Asso. & JCEs | 0 | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 5,256 | 4.244% | 5,042 | 201,423 | (1,244) | (5,456) | |
| Taxation | (4) | -93.750% | (64) | (2) | 0 | (2) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 5,252 | 5.504% | 4,978 | 201,421 | (1,244) | (5,458) | |
| 2025/12 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 1,795 | 34.457% | 1,335 | 48 | 8,964 | 6,712 |
| Depreciation & Amortisation | 1,696 | -40.071% | 2,830 | 1,841 | 732 | 966 |
| Directors' Emoluments | 371 | -11.876% | 421 | 1,074 | 1,139 | 2,417 |
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2025/12 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 5.250 | -16.667% | 6.300 | 321.100 | -11.300 | -50.000 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 0.553 | -- | 0.289 | 0.234865 | (29.142107) | (25.055015) |
| Remarks: | Real time quote last updated: 05/03/2026 11:38 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 5,252 |
| %Change | 5.504% |
| EPS / (LPS) | RMB 0.053 |
| NBV Per Share (¥) | RMB 0.553 |